Dr. Reddy's Laboratories last week won a...

...two-year court battle to sell a generic version of Indivior's Suboxone, a blockbuster drug that can reduce opioid dependence and minimize withdrawal symptoms. Suboxone is the best-selling opioid dependence drug in the U.S., and holds preferred tier placement for 51% of all covered lives. The generic version could now hit the market nearly four years earlier than expected.

SOURCE: MMIT Analytics, as of 3/22/19